In line with the acquisition plans of global pharmaceutical giants, Italian company Menarini is keen on buying out an established product portfolio to strengthen its operations in India. Menarini India, an arm of the $4.2-billion Menarini Group, is in the early stages of discussions with a handful of pharmaceutical companies to acquire brands in the cardiovascular, pain management and gastroenterology segments. According to senior officials, the company is eyeing acquisitions in the range of Rs 500 crore.
Help employers find you! Check out all the jobs and post your resume.
